Paper41300282
Modeling Glioblastoma for Translation: Strengths and Pitfalls of Preclinical Studies.
D'Antonio C and 1 other. Biology (Basel), 2025. Cited by 5 papers, by iCite.
Cite this record
ConductScience Library. Modeling Glioblastoma for Translation: Strengths and Pitfalls of Preclinical Studies. Papers, record 41300282. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41300282
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| CEVITA | European Union-NextGenerationEU | PubMed | ||
| University of Ljubljana VIP project Nanostructurome | PubMed |
Source PubMed
References180
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23333277 | Patient-specific orthotopic glioblastoma xenograft models recapitulate the histopathology and biology of human glioblastomas in situ. | Cell Rep | 2013 | https://conductscience.org/library/papers/23333277 | PubMed |
| 2 | 22183788 | Calpain 2 is required for the invasion of glioblastoma cells in the zebrafish brain microenvironment. | J Neurosci Res | 2012 | https://conductscience.org/library/papers/22183788 | PubMed |
| 3 | 26629530 | The Human Glioblastoma Cell Culture Resource: Validated Cell Models Representing All Molecular Subtypes. | EBioMedicine | 2015 | https://conductscience.org/library/papers/26629530 | PubMed |
| 4 | 39799339 | Personalising glioblastoma medicine: explant organoid applications, challenges and future perspectives. | Acta Neuropathol Commun | 2025 | https://conductscience.org/library/papers/39799339 | PubMed |
| 5 | 11063134 | A quantitative model for differential motility of gliomas in grey and white matter. | Cell Prolif | 2000 | https://conductscience.org/library/papers/11063134 | PubMed |
| 6 | 33329756 | Universal scaling laws rule explosive growth in human cancers. | Nat Phys | 2020 | https://conductscience.org/library/papers/33329756 | PubMed |
| 7 | 29392690 | Establishing Primary Human Glioblastoma Tumorsphere Cultures from Operative Specimens. | Methods Mol Biol | 2018 | https://conductscience.org/library/papers/29392690 | PubMed |
| 8 | 7807177 | Negative effects of wild-type p53 and s-Myc on cellular growth and tumorigenicity of glioma cells. Implication of the tumor suppressor genes for gene therapy. | J Neurooncol | 1994 | https://conductscience.org/library/papers/7807177 | PubMed |
| 9 | 27444372 | Computational models for predicting drug responses in cancer research. | Brief Bioinform | 2017 | https://conductscience.org/library/papers/27444372 | PubMed |
| 10 | 39657679 | Patient-derived glioblastoma organoids as real-time avatars for assessing responses to clinical CAR-T cell therapy. | Cell Stem Cell | 2025 | https://conductscience.org/library/papers/39657679 | PubMed |
| 11 | 37400666 | Glioblastoma research on zebrafish xenograft models: a systematic review. | Clin Transl Oncol | 2024 | https://conductscience.org/library/papers/37400666 | PubMed |
| 12 | 30191323 | Engineered 3D tumour model for study of glioblastoma aggressiveness and drug evaluation on a detachably assembled microfluidic device. | Biomed Microdevices | 2018 | https://conductscience.org/library/papers/30191323 | PubMed |
| 13 | 5475483 | Studies on the chemotherapy of experimental brain tumors: development of an experimental model. | Cancer Res | 1970 | https://conductscience.org/library/papers/5475483 | PubMed |
| 14 | 18467254 | Intravenous administration of arsenic trioxide encapsulated in liposomes inhibits the growth of C6 gliomas in rat brains. | J Chemother | 2008 | https://conductscience.org/library/papers/18467254 | PubMed |
| 15 | 26896279 | A Three-Dimensional Organoid Culture System Derived from Human Glioblastomas Recapitulates the Hypoxic Gradients and Cancer Stem Cell Heterogeneity of Tumors Found In Vivo. | Cancer Res | 2016 | https://conductscience.org/library/papers/26896279 | PubMed |
| 16 | 23630058 | Integration of microfluidic chip with biomimetic hydrogel for 3D controlling and monitoring of cell alignment and migration. | J Biomed Mater Res A | 2014 | https://conductscience.org/library/papers/23630058 | PubMed |
| 17 | 23328810 | Regression of glioma tumor growth in F98 and U87 rat glioma models by the Nitrone OKN-007. | Neuro Oncol | 2013 | https://conductscience.org/library/papers/23328810 | PubMed |
| 18 | 31479239 | Tumor-Derived Extracellular Vesicles Breach the Intact Blood-Brain Barrier via Transcytosis. | ACS Nano | 2019 | https://conductscience.org/library/papers/31479239 | PubMed |
| 19 | 7435138 | Morphological characterization of nitrosourea-induced glioma cell lines and clones. | Acta Neuropathol | 1980 | https://conductscience.org/library/papers/7435138 | PubMed |
| 20 | 34566587 | Comparison Between Human and Rodent Neurons for Persistent Activity Performance: A Biologically Plausible Computational Investigation. | Front Syst Neurosci | 2021 | https://conductscience.org/library/papers/34566587 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42794659 | Molecular Engineering of Aptamers for Glioblastoma Therapy: From Simple Antagonists to AI-Driven Approaches, a Narrative Review. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42794659 | PubMed |
| 42474944 | Mitochondrial stress-induced cuproptosis: a metabolic bridge to reprogramming the GBM immune microenvironment. | Cell Oncol (Dordr) | 2026 | https://conductscience.org/library/papers/42474944 | PubMed |
| 42396877 | Mechanisms of Therapeutic Resistance and Recent Advances in Glioblastoma Treatment. | Immunol Cell Biol | 2026 | https://conductscience.org/library/papers/42396877 | PubMed |
| 42347034 | Optimized Wound Healing Assay to Study Extracellular Vesicle-Driven Glioblastoma Cell Migration. | Methods Protoc | 2026 | https://conductscience.org/library/papers/42347034 | PubMed |
| 42252325 | Overexpression of miR-219 as a potential therapeutic strategy of glioblastoma cells in vitro. | Sci Rep | 2026 | https://conductscience.org/library/papers/42252325 | PubMed |
| 42017986 | Interactions and communications in the glioblastoma microenvironment: potential targets for chemo-/radiotherapy. | Strahlenther Onkol | 2026 | https://conductscience.org/library/papers/42017986 | PubMed |
| 41836519 | Closing the loop on glioblastoma: A roadmap toward developing bioelectronics for continuous monitoring of tumor state. | APL Bioeng | 2026 | https://conductscience.org/library/papers/41836519 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41300282
GET https://conductscience.org/api/papers/v1/41300282/references?page=2